Bal Pharma Limited — Others, 06-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bal Pharma Limited has confirmed that the securities dematerialized and rematerialized during the quarter ended 31.12.2024 have been duly reported to all relevant stock exchanges, in compliance with regulatory timelines. Share certificates received for dematerialization were properly verified, mutilated, and canceled, with records updated to reflect the depository as the registered owner within 15 days.

This update reinforces the company’s commitment to efficient share management, which can enhance investor confidence and operational transparency. A smooth dematerialization process may contribute to a positive outlook for shareholders, minimizing potential risks associated with share trading efficiency.